XML 104 R58.htm IDEA: XBRL DOCUMENT v3.25.2
Subsequent Events (Details)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
employee
Feb. 28, 2025
item
Jan. 31, 2025
USD ($)
Mar. 31, 2025
USD ($)
employee
Dec. 31, 2024
employee
Employee Severance          
Subsequent Event [Line Items]          
Reduction in workforce, number of employees | employee         62
Reduction in workforce (as a percent)         58.00%
Employee Severance | 2025 Cash Preservation Plan          
Subsequent Event [Line Items]          
Reduction in workforce, number of employees | employee       37  
Reduction in workforce (as a percent)       84.00%  
Moderna | Collaboration and License Agreement          
Subsequent Event [Line Items]          
Number of oncology research targets, nominated   10      
Number of research targets, replacement nominations   4      
Number of oncology research targets, ceased development   2      
Number of autoimmune research targets, ceased development   2      
Number of oncology research targets   12      
Subsequent Event | Employee Severance | 2025 Cash Preservation Plan          
Subsequent Event [Line Items]          
Reduction in workforce, number of employees | employee 37        
Reduction in workforce (as a percent) 84.00%        
Expected cost with the reduction in workforce | $ $ 3.8     $ 3.8  
Subsequent Event | Moderna          
Subsequent Event [Line Items]          
Proceeds from collection of collaboration receivable | $     $ 2.9    
Subsequent Event | Moderna | Collaboration and License Agreement          
Subsequent Event [Line Items]          
Number of oncology research targets, nominated   10      
Number of research targets, replacement nominations   4      
Number of oncology research targets, ceased development   2      
Number of autoimmune research targets, ceased development   2      
Number of oncology research targets   12